Evidence map›Paper›PMID 30602369›Full record

ArticleBMC molecular biology2019

Graphene oxide down-regulates genes of the oxidative phosphorylation complexes in a glioblastoma.

Maciej Szmidt, Adrian Stankiewicz, Kaja Urbańska, Sławomir Jaworski, Marta Kutwin, Mateusz Wierzbicki, Marta Grodzik, Beata Burzyńska, Monika Góra, André Chwalibog and 1 more

Open access · hybridAbstract read
In one paragraph

Article in BMC molecular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Maciej SzmidtDepartment of Morphological Sciences, Warsaw University of Life Sciences, 02-787, Warsaw, Poland.
Adrian StankiewiczDepartment of Molecular Biology, Institute of Genetics and Animal Breeding, Polish Academy of Sciences, 05-552, Jastrzebiec, Poland.
Kaja UrbańskaDepartment of Morphological Sciences, Warsaw University of Life Sciences, 02-787, Warsaw, Poland.
Sławomir JaworskiDepartment of Animal Nutrition and Biotechnology, Warsaw University of Life Sciences, 02-787, Warsaw, Poland.
Marta KutwinDepartment of Animal Nutrition and Biotechnology, Warsaw University of Life Sciences, 02-787, Warsaw, Poland.
Mateusz WierzbickiDepartment of Animal Nutrition and Biotechnology, Warsaw University of Life Sciences, 02-787, Warsaw, Poland.
Marta GrodzikDepartment of Animal Nutrition and Biotechnology, Warsaw University of Life Sciences, 02-787, Warsaw, Poland.
Beata BurzyńskaDepartment of Genetics, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106, Warsaw, Poland.
Monika GóraDepartment of Genetics, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106, Warsaw, Poland.
André ChwalibogDepartment of Veterinary and Animal Sciences, University of Copenhagen, Groennegaardsvje 3, 1870, Frederiksberg, Denmark. ach@sund.ku.dk.ORCID 0000-0001-8150-2392
Ewa SawoszDepartment of Animal Nutrition and Biotechnology, Warsaw University of Life Sciences, 02-787, Warsaw, Poland.
Warsaw University of Life Sciences · PLInstitute of Biochemistry and Biophysics, Polish Academy of Sciences · PLPolish Academy of Sciences · PLUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently different forms of nanographene were proposed as the material with high anticancer potential. However, the mechanism of the suppressive activity of the graphene on cancer development remains unclear. We examined the effect of oxygenated, reduced and pristine graphene on the gene expression in glioblastoma U87 cell line.

resultsConducting microarrays and RT-qPCR analysis we explored that graphene oxide (rather than reduced graphene oxide and pristine graphene) down-regulates the mRNA expression of mitochondrial oxidative phosphorylation (OXPHOS) nuclear genes of complexes I, III, IV and V. The presented results provide first evidence for the hypothesis that the suppressed growth of GBM can be the consequence of down-regulation of OXPHOS protein expression and decreased ATP level.

conclusionsWe suggest that changes in the expression of OXPHOS genes identified in our study may mediate the anti-proliferative and anti-migratory effects of graphene oxide in glioblastoma cells. However, further investigations with different cell lines, regarding expression, regulation and activity of OXPHOS genes identified in our study is necessary to elucidate the mechanism mediating the anti-proliferative and anti-migratory effects of graphene oxide in glioblastoma cells.

Indexed as

NanoparticlesAntineoplastic AgentsCell Line, TumorDown-RegulationGene ExpressionGlioblastomaGraphiteHumansMitochondrial Membrane Transport ProteinsOxidative PhosphorylationRNA, MessengerAntineoplastic Agentsgraphene oxideGraphiteMitochondrial Membrane Transport ProteinsRNA, MessengerGene expressionGlioblastomaGrapheneGraphene oxideOXPHOS

Identifiers

PMID30602369
PMCPMC6317254
OpenAlexW2907508030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.